atrasentan has been researched along with methyldopa in 1 studies
| Studies (atrasentan) | Trials (atrasentan) | Recent Studies (post-2010) (atrasentan) | Studies (methyldopa) | Trials (methyldopa) | Recent Studies (post-2010) (methyldopa) |
|---|---|---|---|---|---|
| 358 | 41 | 108 | 3,719 | 420 | 143 |
| Protein | Taxonomy | atrasentan (IC50) | methyldopa (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 5.228 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 5.176 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.126 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelhady, SA; Darwish, IE; El-Deeb, NM; El-Mas, MM; Gowayed, MA; Habib, YH | 1 |
1 other study(ies) available for atrasentan and methyldopa
| Article | Year |
|---|---|
Modulation by antenatal therapies of cardiovascular and renal programming in male and female offspring of preeclamptic rats.
Topics: Animals; Atrasentan; Cardiovascular Diseases; Disease Models, Animal; Endothelin A Receptor Antagonists; Female; Kidney Diseases; Male; Methyldopa; Naphthalenes; NG-Nitroarginine Methyl Ester; Pre-Eclampsia; Pregnancy; Prenatal Care; Propionates; Rats; Receptors, Thromboxane A2, Prostaglandin H2; Sex Factors; Sympatholytics | 2021 |